EUVIMEDEUVIMED entdecken
Open Access

Patient perspectives on elexacaftor/tezacaftor/ivacaftor after lung transplant

Dave Young, Lauren E Bartlett, Jennifer Guimbellot, Tijana Milinic, Nora Burdis, Eliana R Gill, Erika D Lease, Christopher H Goss, Siddhartha G Kapnadak, Kathleen J Ramos

Journal of Cystic Fibrosis · 2024

DOI: 10.1016/j.jcf.2023.09.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2024. Verfasst von Dave Young und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Washington, Seattle, WA 98195, United States. Hauptthemen laut MEDLINE: Lung Transplantation, Cystic Fibrosis, Benzodioxoles, Indoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINR NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationCystic FibrosisBenzodioxolesIndolesAminophenolsQuinolonesPyridinesPyrazolesHumansFemaleMaleAdultChloride Channel AgonistsPyrrolesDrug CombinationsMiddle AgedTransplant RecipientsQuality of LifeSurveys and QuestionnairesPyrrolidines

Substanzen

BenzodioxolesIndolesAminophenolsQuinolonesPyridinesPyrazoleselexacaftorChloride Channel AgoniststezacaftorPyrroles

Autor:innen und Institutionen

  • Department of Biology, University of Washington, Seattle, WA 98195, United States.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA 98195, United States.
  • Division of Biobehavioral Nursing and Health Informatics, Department of Nursing, University of Washington, Seattle, WA 98195, United States.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA 98195, United States; Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Universit…
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA 98195, United States. Electronic address: ramoskj@uw.edu.

Förderung

  • NINR NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • American Thoracic Society
  • National Institutes of Health
  • Cystic Fibrosis Foundation

Zitieren

APA

Young, D., Bartlett, L. E., Guimbellot, J., Milinic, T., Burdis, N., Gill, E. R., Lease, E. D., Goss, C. H., Kapnadak, S. G., & Ramos, K. J. (2024). Patient perspectives on elexacaftor/tezacaftor/ivacaftor after lung transplant. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.09.017

Vancouver

Young D, Bartlett LE, Guimbellot J, Milinic T, Burdis N, Gill ER, et al. Patient perspectives on elexacaftor/tezacaftor/ivacaftor after lung transplant. Journal of Cystic Fibrosis. 2024. doi:10.1016/j.jcf.2023.09.017

BibTeX
@article{Young2024,
  author = {Young, Dave and Bartlett, Lauren E and Guimbellot, Jennifer and Milinic, Tijana and Burdis, Nora and Gill, Eliana R and Lease, Erika D and Goss, Christopher H and Kapnadak, Siddhartha G and Ramos, Kathleen J},
  title = {Patient perspectives on elexacaftor/tezacaftor/ivacaftor after lung transplant},
  journal = {Journal of Cystic Fibrosis},
  year = {2024},
  doi = {10.1016/j.jcf.2023.09.017}
}
Kostenlos starten →